BRADYKININ B2 RECEPTOR GENE POLYMORPHISM ANALYSIS IN HYPERTENSIVE PATIENTS AT DR SAIFUL ANWAR HOSPITAL MALANG

Johan Aloysius, Nashi Widodo

Abstract


Hypertension is a major health problem in the world. When blood volume is low, juxtaglomerular cells in the kidneys secrete renin and prorenin activates the blood circulation. Plasma renin converts angiotensinogen released by the liver into angiotensin I, which is then converted to angiotensin II by the enzyme angiotensin converting enzyme (ACE) located in the pulmonary vascular endothelium. Angiotensin II causes blood vessels to constrict, resulting in increased blood pressure. ACEi inhibit the formation of angiotensin I into angiotensin II, and activate Bradykinin (BK), which causes blood vessels to dilate, thereby reducing blood pressure. However, administration of ACEi periodically cause the accumulation of BK in pulmonary vessels that cause inflammation (cough) in some people who suspected mediated by Bradykinin B2 receptor (BK2R) gene. Total of the subjects in this study is 52 subjects, DNA extracted from white blood cells (leukocytes) as much as 200 mL from whole blood by using the QIAamp kit (Qiagen). Gene BK2R in humans amplified by the method of Polymerase Chain Reaction (PCR) method using the following primers F (5-GCAGAGCTCAGCTGGAGGCG-3), and R (5-CCTCCTCGGAGCCCAGAAG-3) and identified by the method of Single Strand Conformation Polymorphism (SSCP). Results of this study shows three different genotypes there are CC, CT, and TT. Subjects with the CC genotype were most susceptible to cough, and subjects with CT genotype were least susceptible.

 

Keywords : ACE inhibitors, B2 Receptor, Cough, SSCP

Full Text:

PDF

References


Kuoppala A, Lindstedt KA, Saarinen J, Kovanen PT, Kokkonen JO (2000) Inactivation of Bradykinin by Angiotensin-Converting Enzyme and by Carboxypeptidase N in human plasma. Am J Physiol Heart Circ Physiol 278: 1069-1074.

Sweitzer, Nancy K. 2003. What Is an Angiotensin Converting Enzyme Inhibitor? Journal of The American Heart Association. Circulation.

Norman MK and Burton DR (2000) Major Side Effects of ACE Inhibitors. Diabetes Care 14: 34-39.

Yousef, G.M. and Diamandis E.P. 2007. The New Human Tissue Kallikrein Gene Family:Structure, Function and Association to Disease. Endocri Rev 22: 184-204.

Zintzaras E, Raman G, Kitsios G, Lau J. 2008. Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch Intern Med 2008; 168: 1077-1089.

Mukae, S., Aoki, S., Itoh, S., Iwata, T., Ueda, H., and Katagiri, T. 2000. Angiotensin-Converting Enzyme Inhibitor Related Cough Receptor Gene Polymorphism Is Associated With Bradykinin B2 Receptor. Hypertension. 36:127-131.

Qiagen. 2012. DNA Mini and Blood Mini Handbook. Page:26-28. http://www.qiagen.com/ Diakses tanggal 15 November 2013.

Woo, S.W., Bang, S., Chung, M.W., Jin, S.K., Kim, Y.S., Lee, S.H. 2009. Lack of association between ACE and bradykinin B2 receptor gene polymorphisms and ACE inhibitor-induced coughing in hypertensive Koreans. Blackwell Publishing Ltd, Journal of Clinical Pharmacy and Therapeutics, 34, 561–567.

Benbouza, H., Jacquemin, J.M., Baudoin, J.P., Mergeai, G. 2006. Optimization of a reliable, fast, cheap and sensitive silver staining method to detect SSR markers in polyacrylamide gels. Biotechnol. Agron. Soc. Environ.2006 10 (2), 77 – 81.

Zhu, X. Niu, N., Liu, Y., Du, Te., Chen, D., Wang, X., Gu, H.G. 2006. Improvement of the sensitivity and resolution of PCR-SSCP analysis with optimized primer concentrations in PCR products. Journal of Genetics, Vol. 85, No. 3.


Refbacks

  • There are currently no refbacks.